Atrys Health

Atrys Health Rule of 40

The Rule of 40 of Atrys Health (ATRY.MC) as of Nov 21, 2026 is -40.12 %. In the previous year, Rule of 40 was 0.58 % — a change of -6,969.66% (lower).

Rule of 40

-40.12 %

YoY

-6,969.66%

Last updated:

Rule of 40 of Atrys Health is 2025 -40.12 % . Rule of 40 of Atrys Health was 2024 0.58 % . It decreases by -6,969.66% lower compared to the previous year.

The Atrys Health Rule of 40 history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Rule of 40
Date
Rule of 40
Jan 1, 2018
1.40 EUR
Jan 1, 2019
111.59 EUR
Jan 1, 2020
127.19 EUR
Jan 1, 2021
245.54 EUR
Jan 1, 2022
26.46 EUR
Jan 1, 2023
26.50 EUR
Jan 1, 2024
0.58 EUR
Jan 1, 2025
-40.12 EUR
The Atrys Health Rule of 40 history
YEARRule of 40YoY
-40.12 %-6,969.66%
0.58 %-97.80%
26.50 %+0.13%
26.46 %-89.22%
245.54 %+93.05%
127.19 %+13.98%
111.59 %+7,879.27%
1.40 %-96.70%
42.32 %-63.52%
116.02 %-31.94%
170.47 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Atrys Health Stock analysis

What does Atrys Health do? Atrys Health SA is a leading provider of medical services, founded in 2007 in Madrid, Spain, as a spin-off company of the Clinica Universidad de Navarra. The company's goal is to connect the limitless world of science and technology with the human component of healthcare. The business model of Atrys Health specializes in the development of products, services, and solutions in the field of medical imaging and cancer treatment. The company offers innovative technologies and medical services to help diagnose and treat patients better. Atrys Health consists of different business divisions focusing on the needs of clinical practice, research and development, and biotechnological production. The company aims to improve the efficiency and effectiveness of diagnosis, imaging, and treatment technologies to maximize results. The divisions of Atrys Health focus on various aspects of healthcare, including telemedicine, radiology, and proton therapy. Telemedicine provides a platform for remote treatments and medical consultation, improving access to specialists and enabling fast and effective diagnosis and treatment. The radiology division operates diagnostic centers specializing in medical imaging, equipped with the latest imaging technologies. The proton therapy division operates a proton therapy center in Madrid, offering advanced cancer treatment. Atrys Health offers a range of products tailored to the needs of clinical practice, research and development, and biotechnological production. Their key products include Atrilab, a leading platform for precision oncology diagnostics, Auriculum, a technology for precise radiation in cancer treatments, and Vida Oncology, a software solution for cancer treatment management. In conclusion, Atrys Health is a key player in medical imaging and cancer treatment, improving healthcare globally with advanced technologies and services. With their vision of combining innovative technologies with the human component of healthcare, Atrys Health will continue to lead in the healthcare industry. Atrys Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Atrys Health stock

Rule of 40 of Atrys Health is -40.12 % in 2025.

On Eulerpool you can find the complete historical development of Rule of 40 Atrys Health since 2006 – with annual values, charts, and detailed analysis.

The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Atrys Health

All Key Metrics — Atrys Health